Literature DB >> 17543961

Prevalence of the metabolic syndrome and its components in Brazilian women with polycystic ovary syndrome.

Elvira Maria Mafaldo Soares1, George Dantas Azevedo, Rafael Gonçalves Nóbrega Gadelha, Telma Maria Araújo Moura Lemos, Técia Maria Oliveira Maranhão.   

Abstract

OBJECTIVE: To determine the prevalence of the metabolic syndrome (MetS) and its components in Brazilian women with polycystic ovary syndrome (PCOS).
DESIGN: Cross-sectional study.
SETTING: University Hospital, Federal University of Rio Grande do Norte, Natal-RN, Brazil. PATIENT(S): 102 women with PCOS by the Rotterdam consensus criteria. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Clinical and biochemical parameters for MetS as defined by the National Cholesterol Education Program Adult Treatment Panel (NCEP ATP III). RESULT(S): The prevalence for individual components of MetS were high-density lipoprotein cholesterol level <50 mg/dL in 69.6%, waist circumference >or=88 cm in 57.9%, triglyceride level >or=150 mg/dL in 31.7%, blood pressure >or=130/85 mm Hg in 18.6%, and fasting glucose concentrations >or=110 mg/dL in 2.9%. Three or more of these individual criteria were present in 29 (28.4%) of the patients. The prevalence of MetS increased with body mass index: 3.2%, 19.2% and 52.3% for normal, overweight, and obese women, respectively. CONCLUSION(S): These findings indicate that Brazilian women with PCOS have a high prevalence of MetS and its individual components, particularly a decreased high-density lipoprotein cholesterol level. Thus, these women are at increased risk of diabetes mellitus and cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17543961     DOI: 10.1016/j.fertnstert.2007.03.081

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  17 in total

Review 1.  Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.

Authors:  Lara C Morley; Thomas Tang; Ephia Yasmin; Robert J Norman; Adam H Balen
Journal:  Cochrane Database Syst Rev       Date:  2017-11-29

2.  The effects of old, new and emerging medicines on metabolic aberrations in PCOS.

Authors:  Alexandra Bargiota; Evanthia Diamanti-Kandarakis
Journal:  Ther Adv Endocrinol Metab       Date:  2012-02       Impact factor: 3.565

Review 3.  Polycystic ovary syndrome.

Authors:  Zi-Jiang Chen; Yuhua Shi
Journal:  Front Med China       Date:  2010-08-12

4.  Polycystic Ovary Syndrome Signs and Metabolic Syndrome in Premenopausal Hispanic/Latina Women: the HCHS/SOL Study.

Authors:  Michelle L Meyer; Daniela Sotres-Alvarez; Anne Z Steiner; Larry Cousins; Gregory A Talavera; Jianwen Cai; Martha L Daviglus; Laura R Loehr
Journal:  J Clin Endocrinol Metab       Date:  2020-03-01       Impact factor: 5.958

5.  Polycystic ovary syndrome, body mass index and outcomes of assisted reproductive technologies.

Authors:  Hind A Beydoun; Laurel Stadtmauer; May A Beydoun; Helena Russell; Yueqin Zhao; Sergio Oehninger
Journal:  Reprod Biomed Online       Date:  2009-06       Impact factor: 3.828

6.  Prevalence of metabolic syndrome in women with polycystic ovary syndrome attending an infertility clinic in a tertiary care hospital in south India.

Authors:  Kavita Mandrelle; Mohan S Kamath; Dian J Bondu; Achamma Chandy; Tk Aleyamma; Korula George
Journal:  J Hum Reprod Sci       Date:  2012-01

7.  Prevalence of hepatic steatosis in women with polycystic ovary syndrome.

Authors:  Ritu Karoli; Jalees Fatima; Ashok Chandra; Uma Gupta; Faraz-Ul Islam; Gagandeep Singh
Journal:  J Hum Reprod Sci       Date:  2013-01

8.  Description and prediction of the development of metabolic syndrome in Dongying City: a longitudinal analysis using the Markov model.

Authors:  Xiaoxiao Chen; Qicai Chen; Lili Chen; Pengpeng Zhang; Juan Xiao; Shumei Wang
Journal:  BMC Public Health       Date:  2014-10-04       Impact factor: 3.295

9.  Prevalence of metabolic syndrome in polycystic ovarian syndrome women in a hospital of Tehran.

Authors:  Ashraf Moini; Fatemeh Javanmard; Bita Eslami; Najmeh Aletaha
Journal:  Iran J Reprod Med       Date:  2012-03

10.  Polycystic ovary syndrome: aggressive or protective factor for the retina? Evaluation of macular thickness and retinal nerve fiber layers using high-definition optical coherence tomography.

Authors:  José Edvan de Souza-Júnior; Carlos Alexandre de Amorim Garcia; Elvira Maria Mafaldo Soares; Técia Maria Oliveira Maranhão; Telma Maria Araújo Moura Lemos; George Dantas Azevedo
Journal:  J Ophthalmol       Date:  2015-02-11       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.